At some point, someone invested in us. Now it’s our turn. Join me in supporting the #Fight4Hematology and help secure the future of hematology research and care! Support the @ASH_hematology foundation

Kyle needs our help! ⚠️ Diagnosed with leukemia right before his @UCRMBB senior night game, he now urgently needs a blood stem cell transplant. No matches have been found yet, but your cells could be his cure. Join the registry today or share his story 👉 https://t.co/tJbXFt7m1H

Sudan faces a historic crisis. Millions displaced, food insecurity soaring. The Humanitarian Relief & Reconstruction Alliance, led by SAMA & WAV, delivered 863,000+ meals to 28,466 IDPs. 📖 Read the impact: https://t.co/RjPz00UBLP ❤️ Donate now: https://t.co/s6YSf62UTM

New therapeutic targets in MDS were highlighted at #ASH24, with promising early-phase trials for Elritecept, R289, Vibectomab, and DVF890. @AfafOsman7 is optimistic about these developments offering new hope for MDS patients in 2025. 👉Read more: https://t.co/p0YYVBanSc

The rise in cancer in young adults is alarming and we mostly don’t know why

Childbirth at the time of war: 80% of Sudan hospitals are out of service. The tragedy continues.

Happy birthday to our sweetest Abby, the best technician we’ve ever had!!!!

Made it back home after a great weekend in Seattle with @ASH_hematology for the 2025 highlights of ASH!

Congratulations Dr. Naren Epperla, recently appointed as a co-chair for the national HCRN lymphoma committee working group. @huntsmancancer @UofUInternalMed @UofUHealth

#myeloMATCH MM1YA-S01 is enrolling adults ages 18-59 with newly diagnosed high-risk #AML. Randomized 5-arm comparison of induction therapies. Primary endpoint: MRD-negative complete remission rate. https://t.co/tHEbp3R5K6 Co-PI: Tara Lin, MD @KUcancercenter #leusm #AMLsm

The Red Cross of Utah is urging locals to donate blood after severe winter storms caused over 250 Red Cross blood drives to be canceled nationwide. https://t.co/0OGnky4fnw

Your 2025 reminder to REGISTER FOR #WBC25!!!!!

Cancer survivors are growing in number. In the US, nearly half of survivors have lived 10 or more years after diagnosis, while 19% have lived 20 or more years. The prevalence of long-term survivors is expected to increase through 2040. https://t.co/nzjl6sIFE4 #CancerSurvivorship

All the fidget spinners and play dough I need to get me through hours of zoom meetings! Thank you @nsarellano9 #SecretSanta

Pre-HCT #KMT2A MRD by PCR is prognostic for relapse and survival @BloodJournal Pretransplant MRD detection of fusion transcripts is strongly prognostic in KMT2A-rearranged acute myeloid leukemia

You don’t want to miss this!!! #WBC25

HCI researchers Jihyun Song, PhD, and Josef Prchal, MD, have identified a gene variant in a high-altitude Andean population that could predict disease severity and treatment responses in certain blood cancers. https://t.co/q76An3UzBj @UofUHematology

So very proud of @nsarellano9 for giving a beautiful talk at the post-ASH MPN/CML meeting. Of note, she is also a ✨very ✨deserving @ASH_hematology HIP awardee 👀

This week's @Nature editorial The missed opportunities to save lives with genomic data, such as mutations in BRCA1 and 2 https://t.co/pKxYkbPyCG

This test is widely available nowadays so its important to know the implications of an abnormal study. My amazing friend Shiela Rajagopal is not on twitter but she contributed to this important project. Glad the publication is in NEJM!